Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedMay 11, 2025
DataAggregated Company Financials
Companies7
  • 7D-2.2%
  • 3M-5.4%
  • 1Y-1.2%
  • YTD3.6%

Over the last 7 days, the Life Sciences industry has dropped 2.2%, driven by a pullback from Lonza Group of 2.5%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 11 May 2025CHF 53.8bCHF 10.1bCHF 1.0b31.1x51.8x5.3x
Tue, 08 Apr 2025CHF 44.8bCHF 10.1bCHF 1.0b27.1x43.7x4.4x
Thu, 06 Mar 2025CHF 54.9bCHF 10.1bCHF 1.0b30.6x52.6x5.4x
Sat, 01 Feb 2025CHF 56.6bCHF 10.1bCHF 1.0b36.4x56.2x5.6x
Mon, 30 Dec 2024CHF 52.9bCHF 10.2bCHF 943.4m35.6x56.1x5.2x
Wed, 27 Nov 2024CHF 53.6bCHF 10.2bCHF 943.7m40.6x56.8x5.3x
Fri, 25 Oct 2024CHF 56.1bCHF 10.2bCHF 943.5m42.2x59.4x5.5x
Sun, 22 Sep 2024CHF 55.1bCHF 10.2bCHF 943.1m42.7x58.5x5.4x
Tue, 20 Aug 2024CHF 57.2bCHF 10.2bCHF 914.5m46.1x62.5x5.6x
Thu, 18 Jul 2024CHF 54.6bCHF 10.3bCHF 1.0b47.4x54.5x5.3x
Sat, 15 Jun 2024CHF 51.8bCHF 10.3bCHF 1.0b44.3x51.7x5x
Mon, 13 May 2024CHF 55.2bCHF 10.3bCHF 1.0b44.3x55.1x5.4x
Wed, 10 Apr 2024CHF 57.1bCHF 10.3bCHF 1.0b45.9x57x5.6x
Fri, 08 Mar 2024CHF 51.9bCHF 10.2bCHF 982.0m47.9x52.9x5.1x
Sun, 04 Feb 2024CHF 46.5bCHF 10.2bCHF 1.0b41.3x45.7x4.6x
Tue, 02 Jan 2024CHF 41.9bCHF 9.8bCHF 1.5b32.5x28x4.3x
Thu, 30 Nov 2023CHF 40.4bCHF 9.8bCHF 1.5b30x27x4.1x
Sat, 28 Oct 2023CHF 36.6bCHF 9.8bCHF 1.5b25.6x24.5x3.7x
Mon, 25 Sep 2023CHF 46.5bCHF 9.8bCHF 1.5b32.2x31.2x4.8x
Wed, 23 Aug 2023CHF 51.4bCHF 9.7bCHF 1.5b35.5x34.5x5.3x
Fri, 21 Jul 2023CHF 57.0bCHF 9.7bCHF 1.6b35.3x34.9x5.9x
Sun, 18 Jun 2023CHF 59.2bCHF 9.7bCHF 1.6b38.2x36.3x6.1x
Tue, 16 May 2023CHF 61.6bCHF 9.7bCHF 1.6b39.7x37.7x6.4x
Thu, 13 Apr 2023CHF 60.5bCHF 9.7bCHF 1.7b42.7x36.2x6.2x
Sat, 11 Mar 2023CHF 55.9bCHF 9.6bCHF 1.7b32.6x33.6x5.8x
Mon, 06 Feb 2023CHF 58.0bCHF 9.6bCHF 1.6b33.7x35.5x6.1x
Wed, 04 Jan 2023CHF 50.6bCHF 9.2bCHF 1.3b37.6x38.1x5.5x
Fri, 02 Dec 2022CHF 55.1bCHF 9.2bCHF 1.3b41.5x41.5x6x
Sun, 30 Oct 2022CHF 53.2bCHF 9.2bCHF 1.3b42x40x5.8x
Tue, 27 Sep 2022CHF 46.4bCHF 9.2bCHF 1.3b35.9x35.9x5.1x
Thu, 25 Aug 2022CHF 55.6bCHF 9.1bCHF 1.3b41.5x43.6x6.1x
Sat, 23 Jul 2022CHF 58.1bCHF 8.5bCHF 1.1b35x53.9x6.9x
Mon, 20 Jun 2022CHF 51.8bCHF 8.5bCHF 1.1b45.6x48x6.1x
Wed, 18 May 2022CHF 56.5bCHF 8.5bCHF 1.1b45.3x52.4x6.7x
Price to Earnings Ratio

52.4x


Total Market Cap: CHF 56.5bTotal Earnings: CHF 1.1bTotal Revenue: CHF 8.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 44.8x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 51.8x which is higher than its 3-year average PE of 44.8x.
  • The industry is trading close to its 3-year average PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.84%
Healthcare-3.21%
Life Sciences-2.20%
Clinical Research and Equipment-2.20%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PPGN PolyPeptide GroupCHF 20.152.3%
+CHF 14.8m		-37.1%PS2.1x
XLS Xlife SciencesCHF 20.505.1%
+CHF 5.7m		-41.9%PE3.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

LONN

CHF 584.80

Lonza Group

7D

-2.5%

1Y

11.1%

SKAN

CHF 68.40

SKAN Group

7D

-1.9%

1Y

-14.7%

TECN

CHF 162.40

Tecan Group

7D

-1.6%

1Y

-50.8%

SFZN1

CHF 97.60

Siegfried Holding

7D

-1.3%

1Y

13.8%

BANB

CHF 50.65

Bachem Holding

7D

-1.4%

1Y

-39.3%

XLS

CHF 20.50

Xlife Sciences

7D

5.1%

1Y

-41.9%

PPGN

CHF 20.15

PolyPeptide Group

7D

2.3%

1Y

-37.1%